About Sidharath Gupta
Sidharath’s passion for financial markets and love for words guided his way to become a financial writer. He began his career as an Equity Analyst researching stocks and preparing in-depth research reports. Sidharath is currently pursuing the CFA program to deepen his knowledge of financial analysis and investment strategies.
Sidharath’s daily coverage of the financial markets keeps him on top of key trends, with the goal of helping investors make well-informed decisions.
Recent Articles By Sidharath Gupta
3 Companies CHALLENGING Amazon's Dominance
E-commerce was booming even before the pandemic. And the fears related to the virus have accelerated the growth of online retail business for companies like Walmart (WMT), Costco Wholesale (COST), and Target Corporation (TGT). If these stocks maintain their growth rates, they could challenge the dominance of the giant in this market, Amazon.com (AMZN).
Should You Buy Shares of CrowdStrike Under $150?
The work-and-learn-from-home trend triggered by the pandemic has escalated the demand for cybersecurity tools. CrowdStrike Holdings (CRWD) has immensely benefited from the demand and has returned 175% year-to-date. However, the stock has lost nearly 4.4% over the past month. Find out whether you should buy the dip.
3 Extremely CHEAP Dividend Stocks
The economy is still weak and looming unknowns like the election and stimulus package are expected to keep the market highly volatile. So, affordable dividend-paying stocks like MetLife (MET), The Kroger Company (KR), and Nexstar Media Group (NXST) could be the best choices now, providing safety and income for investors.
Should You Buy Shares of Royal Caribbean as We Head into 2021?
The tourism industry was hit hard by the coronavirus pandemic, causing stocks like Royal Caribbean Cruises (RCL) to head into rough weather and choppy waters. Is it time to scoop up shares.
4 Biotech Stocks Showing Strength During the Market Selloff in September
While the market has mainly sold-off this month, four biotech stocks have showed strength in anticipation of successful drug candidates: Arena Pharmaceuticals (ARNA), Fate Therapeutics (FATE), Kura Oncology (KURA), and Stoke Therapeutics (STOK).
Is Electric Vehicle Maker Nio a Buy at $20?
With a year-to-date gain of 368%, electric vehicle maker NIO Inc. (NIO) is one of the most exciting stocks in the market right now. However, the stock is down close to 10% from its all-time high to trade below $20. Find out whether you should buy the dip.
Will Shares of Shopify Follow in Amazon's Footsteps?
E-commerce was one of the fastest-growing segments of the market prior to the coronavirus. The coronavirus resulted in acceleration. As a result, Amazon (AMZN) and Shopify (SHOP) are two of the strongest stocks.
4 Buy-Rated Stocks Reporting Earnings This Week
The market has been forward-looking in terms of not punishing companies for missing earnings in the last couple of quarters. Due to the recent rally, earnings are going to matter once again. Keep an eye on PepsiCo (PEP), Micron Technology (MU), IHS Markit (INFO), and McCormick & Company (MKC) who are scheduled to report quarterly results this week for early clues.
4 "Strong Buy" Medical Device Stock to Own for the NEXT Decade
Medical device stocks look attractive on a long-term and short-term basis. In the long-term, the demand for medical devices continues to increase due to the aging population. In the short-term, there's pent-up demand from the coronavirus leading to a reduction in medical visits and procedures. Edwards Lifesciences (EW), Align Technology (ALGN), Varian Medical Systems (VAR), and Insulet Corporation (PODD) are three stocks to consider.